TECOGEN INC.·4

Jun 30, 8:32 PM ET

Lewis Earl 4

4 · TECOGEN INC. · Filed Jun 30, 2026

Research Summary

AI-generated summary of this filing

Updated

Tecogen Director Lewis Earl Receives Award for 25,000 Shares

What Happened

  • Lewis Earl, a director of Tecogen Inc. (TGEN), was granted a derivative award for 25,000 shares on 2026-06-26. The reported price associated with the award is $5.17 per share, for a total reported value of $129,250. This transaction is an acquisition/award (not a sale).

Key Details

  • Transaction date: 2026-06-26; Filing date: 2026-06-30 (filed timely).
  • Transaction type: A (grant/award of a derivative security).
  • Shares/units: 25,000; Price shown: $5.17; Total value reported: $129,250.
  • Vesting: Vests 25% per year (footnote), implying a four-year vesting schedule.
  • Shares owned after transaction: Not disclosed in the filing.
  • No 10b5-1 plan, tax-withholding, or late-filing flags indicated in the filing.

Context

  • This was a derivative equity award (commonly RSUs or similar units) that will convert to or permit acquisition of common shares according to the vesting schedule; it does not reflect an immediate open-market purchase or sale. Such awards are typically part of compensation and should be interpreted as an acquisition of equity-linked compensation rather than an immediate liquidity action.

Insider Transaction Report

Form 4
Period: 2026-06-26
Lewis Earl
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    [F1]
    2026-06-26$5.17/sh+25,000$129,25025,000 total
    Exercise: $5.17From: 2027-06-26Exp: 2036-06-26Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]Vests 25% per year
Signature
/s/ Earl R. Lewis|2026-06-30

Documents

1 file
  • 4
    wk-form4_1782865962.xmlPrimary

    FORM 4